$206.00

SR9009 Stenabolic, sold as SHRED: a 20 mg/ml, 30 ml research solution of a Rev-Erb agonist studied in circadian and metabolic research. Third-party tested and shipped same day from Australia.

For laboratory research use only. Not for human consumption. Ships from Australia.